V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004617 | 220001833 | 1.45 | null | null | 2016-09-12 | 2016-09-12 | Cytarabine Low Dose | N | N | 220026427 | CYTARABINE |
| 220004618 | 220021698 | 1.67 | null | Curative (C) | 2014-09-28 | 2014-10-10 | Trial Unspecified | 01 | N | 220026437 | TRIAL |
| 220004619 | 220021698 | null | null | Disease modification (D) | 2013-03-28 | 2013-03-28 | CYTARABINE | N | N | 220026437 | CYTARABINE |
| 220004620 | 220001834 | 1.73 | 67.55 | Disease modification (D) | 2016-01-19 | 2016-02-02 | Cytarabine Low Dose | 02 | N | 220026446 | CYTARABINE |
| 220004621 | 220010931 | 1.56 | 116 | null | 2014-10-24 | 2014-10-25 | AML17 TRIAL | 1 | N | 220026447 | AML17 TRIAL |
| 220004623 | 220001836 | 1.73 | 61.1 | Palliative (P) | 2016-06-03 | 2016-06-03 | Trial Unspecified | 01 | null | 220026453 | TRIAL |
| 220004624 | 220010932 | 1.65 | 91.1 | Palliative (P) | 2017-08-27 | 2017-08-28 | Trial Unspecified | Y | null | 220026455 | TRIAL |
| 220004625 | 220010932 | 1.77 | 98 | Disease modification (D) | 2015-07-22 | 2015-07-22 | Cytarabine Low Dose | 02 | N | 220026455 | CYTARABINE |
| 220004626 | 220001837 | 1.6 | null | Curative (C) | 2013-05-28 | 2013-05-29 | AML17 TRIAL | 02 | N | 220026461 | AML17 TRIAL |
| 220004627 | 220001837 | 1.82 | 70.6 | Curative (C) | 2016-11-12 | 2016-11-16 | AML17 TRIAL | 01 | N | 220026461 | AML17 TRIAL |
| 220004628 | 220001838 | 1.69 | 81.6 | Curative (C) | 2016-05-25 | 2016-05-25 | AML17 TRIAL | N | N | 220026466 | AML17 TRIAL |
| 220004629 | 220001839 | 1.6 | 67.5 | Not known (9) | 2017-03-11 | 2017-03-16 | AML17 TRIAL | Y | N | 220026469 | AML17 TRIAL |
| 220004630 | 220001839 | null | 40.9 | Palliative (P) | 2013-10-23 | 2013-10-23 | AML17 TRIAL | 1 | N | 220026469 | AML17 TRIAL |
| 220004631 | 220001840 | 1.62 | null | Disease modification (D) | 2014-07-12 | 2014-08-14 | Trial Unspecified | Y | N | 220026472 | TRIAL |
| 220004632 | 220001840 | 1.72 | 79.5 | Palliative (P) | 2013-03-02 | 2013-03-03 | LI-1 TRIAL | 01 | null | 220026472 | TRIAL |
| 220004633 | 220001840 | 1.6 | null | Curative (C) | 2017-11-25 | 2017-11-28 | Trial Unspecified | 1 | null | 220026472 | TRIAL |
| 220004634 | 220001840 | 1.73 | 58 | Palliative (P) | 2015-02-26 | 2015-02-27 | Cytarabine Low Dose | N | N | 220026472 | CYTARABINE |
| 220004635 | 220001841 | 1.72 | 57 | Curative (C) | 2014-12-10 | 2014-12-11 | AML17 TRIAL | N | N | 220026483 | AML17 TRIAL |
| 220004636 | 220001841 | 1.75 | 69 | null | null | 2014-01-29 | Trial Unspecified | Y | N | 220026483 | TRIAL |
| 220004637 | 220001841 | 1.7 | 0 | null | 2018-01-03 | 2018-01-16 | Cytarabine Low Dose | N | N | 220026483 | CYTARABINE |
| 220004638 | 220001841 | 1.72 | 63 | Palliative (P) | 2015-10-13 | 2015-11-09 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026483 | CYTARABINE |
| 220004639 | 220001841 | 1.77 | null | Disease modification (D) | 2015-12-03 | 2015-12-11 | Trial Unspecified | 1 | null | 220026483 | TRIAL |
| 220004640 | 220001842 | 1.8 | 86.5 | Curative (C) | 2013-12-21 | 2013-12-21 | Trial Unspecified | 1 | N | 220026491 | TRIAL |
| 220004641 | 220010937 | null | null | Curative (C) | 2017-11-23 | 2017-11-23 | AML17 TRIAL | Y | N | 220026492 | AML17 TRIAL |
| 220004642 | 220001843 | 1.53 | null | Palliative (P) | 2015-04-20 | 2015-04-23 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026494 | CYTARABINE |
| 220004643 | 220010938 | 1.74 | 106.6 | Not known (9) | 2016-06-28 | 2016-07-02 | AML17 TRIAL | Y | N | 220026496 | AML17 TRIAL |
| 220004644 | 220010938 | null | 56 | Palliative (P) | 2013-05-13 | 2013-05-17 | Trial Unspecified | Y | N | 220026496 | TRIAL |
| 220004654 | 220001844 | 1.64 | null | Disease modification (D) | null | 2015-02-20 | Cytarabine Low Dose | 02 | N | 220026517 | CYTARABINE |
| 220004655 | 220001844 | 1.67 | 86.8 | null | 2017-03-04 | 2017-03-12 | Cytarabine Low Dose | 2 | N | 220026517 | CYTARABINE |
| 220004656 | 220001845 | 1.82 | null | Curative (C) | 2016-04-29 | 2016-04-29 | Trial Unspecified | 01 | N | 220026519 | TRIAL |
| 220004657 | 220001846 | 1.78 | 57.5 | null | 2014-05-17 | 2014-05-17 | CYTARABINE | 2 | N | 220026523 | CYTARABINE |
| 220004658 | 220001847 | 0 | 96.2 | Not known (9) | null | 2014-01-31 | AML17 TRIAL | 02 | null | 220026524 | AML17 TRIAL |
| 220004659 | 220001847 | 1.7 | 50 | Curative (C) | 2013-03-03 | 2013-03-05 | AML17 TRIAL | 1 | null | 220026524 | AML17 TRIAL |
| 220004660 | 220015838 | null | null | Disease modification (D) | 2015-07-22 | 2015-07-22 | Cytarabine Low Dose | N | N | 220026526 | CYTARABINE |
| 220004661 | 220001848 | null | 73.2 | Curative (C) | 2016-09-08 | 2016-09-08 | AML17 TRIAL | Y | N | 220026530 | AML17 TRIAL |
| 220004662 | 220001849 | 1.66 | null | Curative (C) | 2017-07-04 | 2017-07-05 | AML17 TRIAL | Y | N | 220026531 | AML17 TRIAL |
| 220004663 | 220001849 | 1.69 | 116 | Curative (C) | 2013-11-24 | 2013-11-26 | AML17 TRIAL | Y | N | 220026531 | AML17 TRIAL |
| 220004664 | 220015839 | 1.56 | 58 | Curative (C) | null | 2017-06-18 | AML17 TRIAL | N | N | 220026534 | AML17 TRIAL |
| 220004665 | 220015839 | 1.83 | null | Curative (C) | 2017-12-03 | 2017-12-03 | Trial Unspecified | null | null | 220026534 | TRIAL |
| 220004666 | 220001850 | 1.77 | 0 | Disease modification (D) | 2015-10-10 | 2015-10-23 | Cytarabine Low Dose | 2 | N | 220026539 | CYTARABINE |
| 220004667 | 220010942 | 1.81 | 59 | Curative (C) | 2014-11-15 | 2014-11-15 | LI-1 TRIAL | Y | N | 220026542 | TRIAL |
| 220004668 | 220001851 | null | null | Curative (C) | null | 2015-11-15 | Trial Unspecified | null | null | 220026546 | TRIAL |
| 220004669 | 220001851 | 1.64 | null | Curative (C) | 2015-10-13 | 2015-10-16 | Cytarabine Low Dose | N | N | 220026546 | CYTARABINE |
| 220004670 | 220001852 | 1.76 | 104.7 | Curative (C) | 2017-03-07 | 2017-03-09 | Trial Unspecified | Y | N | 220026551 | TRIAL |
| 220004671 | 220010944 | 1.62 | 0 | null | 2018-02-13 | 2018-02-13 | Cytarabine Low Dose | N | N | 220026553 | CYTARABINE |
| 220004672 | 220001853 | 1.69 | 98.2 | Palliative (P) | 2013-03-24 | 2013-03-24 | CYTARABINE | null | null | 220026554 | CYTARABINE |
| 220004673 | 220001853 | 1.91 | 45 | null | 2013-02-21 | 2013-02-24 | Cytarabine Low Dose | 02 | N | 220026554 | CYTARABINE |
| 220004677 | 220001855 | 0 | 93.1 | null | 2017-08-17 | 2017-08-17 | AML17 TRIAL | null | N | 220026569 | AML17 TRIAL |
| 220004678 | 220001856 | 1.44 | 91 | Not known (9) | 2017-08-27 | 2017-09-02 | AML17 TRIAL | N | N | 220026570 | AML17 TRIAL |
| 220004679 | 220001856 | null | 62 | Curative (C) | 2016-11-18 | 2016-11-18 | AML17 TRIAL | N | N | 220026570 | AML17 TRIAL |